Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.